Оксана Петровна Власова
Lomonosov Moscow State University · 31 works · 33 citations · h-index 3
Top works
- Radioligand therapy with 177Lu-DOTA-PSMA in metastatic castration-resistant prostate cancer. Pharmacokinetics, safety, antitumour efficacy
- Radioactivity distribution in the blood and urine of patients receiving systemic therapy with a 177Lu radiopharmaceutical and local (intra-articular) therapy with a 188Re radiopharmaceutical
- Results of Preclinical Safety Tests of Radiopharmaceutical with 90Y for Intra-arterial Radioembolization of Liver Cancer
- New Radiopharmaceuticals Based on Prostate-Specific Inhibitors of Membrane Antigen for Diagnostics and Therapy of Metastatic Prostate Cancer
- Personalized dosimetry of internal exposure to foci and organs at risk of patients: development and implementation of a methodological basis for dosimetric support of clinical trials of therapeutic radiopharmaceuticals
- Regulatory Requirements for Small-Scale Preparation of Radiopharmaceuticals
- Radiolabeled somatostatin analogs for cancer treatment. Review
- PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer
- Распределение 177Lu-ДОТА-ПСМА в организме мышей с карциномой предстательной железы 22Rv1
- The Pre-clinical Test’s Results of the Efficiency of the Radiopharmaceutical Preperation "DTPA-Microspheres of Albumin, 90Y"
- Biodistribution of 177Lu-DOTA-PSMA in Mice with Prostate Carcinoma 22Rv1
- Clinical study’s results of the safety of the radiopharmaceutical labeled with Re-188 during intraarterial radioembolization
- Pharmacokinetic Properties of 99mTc-PSMA: A New Radiopharmaceutical for SPECT Imaging of Prostate Cancer
- Radiopharmaceutical development based on human blood albumin microspheres and 90Y
- Проведение исследований по связыванию 90Y с модифицированными микросферами альбумина крови человека и изучение функциональной пригодности образцов РФП
- The possibilities of prostate cancer radioligand therapy with low-molecular-weight PSMA inhibitors labeled with actinium-225: a review
- 99mTc-Labelled Low Molecular Weight Inhibitors of Prostate-Specific Membrane Antigen
- Математическое моделирование для дозиметрического планирования радиойодтерапии пациентов с заболеваниями щитовидной железы
- Results of safety study of radiopharmaceutical drug preparation based on albumin microspheres of 5-10 μm diameter labeled with rhenium-188
- Фармакокинетика 99m Tc-ПСМА – нового радиофармпрепарата для ОФЭКТ визуализации рака предстательной железы